Pivotal Development

Phase 2

We build the commercial architecture that pivotal results will run on. By the time data reads out, the brand, the economics, and the stakeholder strategy need to be ready to move.

Phase Overview

Pivotal Development is the phase where a company commits to the definitive technical, regulatory, and clinical work required to support a regulatory submission. On a PMA pathway that typically means an IDE-approved pivotal trial with formal endpoints designed to meet FDA requirements. On a 510(k) or De Novo pathway it means intensive pre-submission preparation: bench testing, biocompatibility, substantial equivalence documentation, and design validation, without a formal clinical trial. Either way, this is a decisive phase. It's also where health economics work begins, payer strategy takes shape, and the commercial brand architecture needs to be largely locked before data readout or submission.

Brand Architecture

The full brand structure defined and locked, covering how your organization, device, and future portfolio relate to one another.

Health Economics Narrative

The economic case built and articulated, establishing the value argument payers and health systems will eventually evaluate.

Payer Strategy & Messaging

Reimbursement positioning advanced and payer-facing messaging developed ahead of the coverage conversations to come.

KOL Relationship Formalization

Early clinical relationships formalized into advisory, investigator, and advocacy roles that carry into launch.

Product Brand Strategy

Device positioning, differentiation, and messaging finalized against the competitive set you'll launch into.

Brand Book & Style Guide

Brand standards formalized so internal teams, partners, and regulatory submissions stay consistent under pressure.

Marketing Strategy

The go-to-market strategy developed and aligned to your clinical value, regulatory pathway, and commercialization goals.

Investor Strategy

The investment narrative positioned around pivotal execution and the commercial opportunity beyond it.

NEXT PHASE

Regulatory Submission

With the commercial architecture locked and pivotal work complete, your program moves into Regulatory Submission, where the filing goes in and launch preparation begins in earnest.

Continue